series-b
Stage
2
Investors
About
Alveolus develops inhaled biotherapeutics using a proprietary platform to deliver targeted bacteria to the lungs for treating chronic lung diseases such as idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Explore Alveolus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.